MOLECULAR BIOLOGICAL FACTORS OF PROGNOSIS AND EFFICIENCY OF MEDICAL TREATMENT FOR DISSEMINATED RENAL CELL CARCINOMA

MOLECULAR BIOLOGICAL FACTORS OF PROGNOSIS AND EFFICIENCY OF MEDICAL TREATMENT FOR DISSEMINATED RENAL CELL CARCINOMA

Show other versions (1)

The substantial improvement of treatment results in patients with disseminated forms of renal cell carcinoma (RCC) is associated with the active clinical application of target drugs that affect the molecular genetic mechanisms underlying the development of this disease. Inactivation of the VHL gene...

Full description

Bibliographic Details
Main Authors:	D. A. Nosov, E. S. Yakovleva, D. A. Atayeva, L. N. Lyubchenko, S. A. Tyulyandin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-08-01
Series:	Onkourologiâ
Subjects:	renal cell carcinoma target therapy vhl gene mutation hypoxia-induced factor vascular endothelial growth factor biomarkers
Online Access:	https://oncourology.abvpress.ru/oncur/article/view/328

Similar Items

MOLECULAR BIOLOGICAL FACTORS OF PROGNOSIS AND EFFICIENCY OF MEDICAL TREATMENT FOR DISSEMINATED RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01)

PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01)

PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01)

Von Hippel-Lindau Syndrome: Characterization of a Potentially Novel VEGF-A Isoform and Elucidation of Molecular and Vascular Mechanisms of Observed Phenotypic Changes
by: North, Morgan Hunter
Published: (2020)

THE AUTHOR’S EXPERIENCE IN USING BEVACIZUMAB PLUS INTERFERON ALFA-2A IN PATIENTS WITH DISSEMINATED RENAL CELL CARCINOMA
by: A. M. Popov, et al.
Published: (2014-08-01)

THE AUTHOR’S EXPERIENCE IN USING BEVACIZUMAB PLUS INTERFERON ALFA-2A IN PATIENTS WITH DISSEMINATED RENAL CELL CARCINOMA
by: A. M. Popov, et al.
Published: (2014-08-01)

Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells
by: Wohlrab C, et al.
Published: (2019-05-01)

Discoveries of how cells sense oxygen win the 2019 Nobel Prize in Physiology or medicine
by: Cheng-Chia Lee, et al.
Published: (2020-10-01)

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
by: Virginia Albiñana, et al.
Published: (2017-06-01)

Expression of hypoxia inducible factor-1α and vascular endothelial growth factor-C in human chronic periodontitis
by: Qing-Yan Shi, et al.
Published: (2015-09-01)

Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence
by: George Andrea L, et al.
Published: (2012-10-01)

A Novel Role for Tid1 in HIF2α Regulation
by: Burnett, David
Published: (2009)

A Novel Role for Tid1 in HIF2α Regulation
by: Burnett, David
Published: (2009)

Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats
by: Naoki Ishiuchi, et al.
Published: (2020-03-01)

Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients
by: Isaac Almendros, et al.
Published: (2018-04-01)

Molecular Characterization of the von Hippel-Lindau Tumour Suppressor Protein
by: Russell, Ryan
Published: (2009)

Molecular Characterization of the von Hippel-Lindau Tumour Suppressor Protein
by: Russell, Ryan
Published: (2009)

REGULATION OF BONE MARROW ANGIOGENESIS BY OSTEOBLASTS DURING BONE DEVELOPMENT AND HOMEOSTASIS
by: Ernestina eSchipani, et al.
Published: (2013-07-01)

Formononetin, an active compound of Astragalus membranaceus (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1α/VEGF signaling pathway
by: Wu J, et al.
Published: (2016-09-01)

Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway
by: Jianming Wu, et al.
Published: (2016-12-01)

Roxadustat attenuates hyperoxia-induced lung injury by upregulating proangiogenic factors in newborn mice
by: Liang-Ti Huang, et al.
Published: (2021-07-01)

Hypoxia-Inducible Factor-2 Alpha as a Novel Target in Renal Cell Carcinoma
by: WonSeok W. Choi, et al.
Published: (2021-04-01)

Intermittent Hypoxia Influences Alveolar Bone Proper Microstructure via Hypoxia-Inducible Factor and VEGF Expression in Periodontal Ligaments of Growing Rats
by: Shuji Oishi, et al.
Published: (2016-09-01)

Myeloid HIF-1 attenuates the progression of renal fibrosis in murine obstructive nephropathy
by: Yu Tateishi, et al.
Published: (2015-02-01)

Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
by: Thomas Briston, et al.
Published: (2021-09-01)

Tongxinluo Inhibits Cyclooxygenase-2, Inducible Nitric Oxide Synthase, Hypoxia-inducible Factor-2α/Vascular Endothelial Growth Factor to Antagonize Injury in Hypoxia-stimulated Cardiac Microvascular Endothelial Cells
by: Yan-Ning Li, et al.
Published: (2015-01-01)

Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)

The expression of HIT-1α and VEGF in proliferative diabetic retinopathy epiretinal membranes
by: Jian-Feng Cao, et al.
Published: (2013-05-01)

VHL and Hypoxia Signaling: Beyond HIF in Cancer
by: Jing Zhang, et al.
Published: (2018-03-01)

Mutations in the von Hippel-Lindau Tumour Suppressor Gene in Central Nervous System Hemangioblastomas
by: Cybulski Cezary, et al.
Published: (2004-03-01)

VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
by: Thomas Briston, et al.
Published: (2018-10-01)

Hypoxia-inducible factor-1α, vascular endothelial growth factor, inducible nitric oxide synthase, and endothelin-1 expression correlates with angiogenesis in congenital heart disease
by: Hsin-Ling Yin, et al.
Published: (2016-07-01)

Effect of calcium dobesilate on fundus microcirculation in patients with diabetic retinopathy and cataract
by: Xue-Mei Wu, et al.
Published: (2018-05-01)

Lesion size is exacerbated in hypoxic rats whereas hypoxia-inducible factor 1 alpha and vascular endothelial growth factor increase in injured normoxic rats: a prospective cohort study of secondary hypoxia in focal traumatic brain injury.
by: Eric Peter Thelin, et al.
Published: (2016-03-01)

Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation
by: Peizhong Kong, et al.
Published: (2020-05-01)

Expressions of endoplasmic reticulum stress related protein, hypoxia-inducible factor-1α and vascular endothelial growth factor in the retina of diabetic rats
by: Jing Wang, et al.
Published: (2015-05-01)

Hypoxia-induced factor-1 alpha, vascular endothelial growth factor expression in BRCA1-related breast cancer: A prospective study in tertiary care hospital
by: Manisha Sharma, et al.
Published: (2017-01-01)

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
by: Soohwan Yum, et al.
Published: (2017-12-01)

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
by: Gong, K., et al.
Published: (2022)

Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules
by: Kazuya Kabei, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_7duq4ttsq40bs60sorjei4m7bc